AOD-9604 5mg: Dosage, Reconstitution & Research Protocol Guide

AOD-9604 5mg Vial Specifications

Peptide

AOD-9604 (5 mg Vial) (NNMT inhibitor)

Vial Content

5 mg total peptide

Category

Metabolic / Weight Loss

Administration Method

Subcutaneous injection

Common Use Case

Fat metabolism and body composition optimization

AOD-9604 Mechanism of Action

AOD-9604 (Anti-Obesity Drug 9604) is a modified peptide fragment consisting of the terminal 15 amino acids of human growth hormone (positions 176-191) with a tyrosine residue added at the N-terminus for stability. The peptide works by selectively activating lipolysis (fat breakdown) in adipose tissue while inhibiting lipogenesis (fat storage). Research demonstrates that AOD-9604 upregulates beta-3 adrenergic receptors in fat cells, promoting energy expenditure and fat oxidation through mechanisms distinct from traditional stimulants or full growth hormone. Critically, AOD-9604 does not elevate IGF-1 levels or impair glucose metabolism.

AOD-9604 Research Findings and Observed Outcomes

Findings and reported areas of study for AOD-9604 (5 mg Vial) include:

• Selective fat metabolism activation
• No impact on insulin sensitivity or IGF-1 levels
• Support for body composition optimization
• Appetite-neutral approach to fat loss

These observations are discussed for research and educational reference only and are not medical claims.

AOD-9604 5mg Supplies for Reconstitution and Handling

• •Sterile syringes (≥3 mL capacity for diluent)
• •Insulin syringes (0.3 mL or 0.5 mL with 29–31 gauge needles)
• •Bacteriostatic water
• •Alcohol prep pads
• •Sharps disposal container
• •Labels or marker for dating reconstituted vials

Supplies listed are for laboratory handling and research preparation purposes only.

AOD-9604 Injection Route, Frequency and Timing

Inject into abdominal fat region. Rotate injection sites to maintain tissue tolerance. Wait at least 30 minutes before eating after injection.

AOD-9604 Dosage Ranges

The ranges below pair the listed dose with the draw volume for this product strength.

AOD-9604 5mg Dosage to Syringe Units

Based on reconstitution below

This dosing table is unique to the 5 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

AOD-9604 5mg Duration by Research Dose

At common research doses, one 5 mg vial of AOD-9604 typically supports:

Extended metabolic research protocols of 12–24 weeks are commonly studied in clinical settings.

AOD-9604 5mg Reconstitution With Bacteriostatic Water

This section applies specifically to the AOD-9604 (5 mg Vial).

Recommended Diluent

Bacteriostatic water

Diluent Volume

2 mL

Final Concentration

2.5 mg/mL (2,500 mcg/mL)

AOD-9604 and Compatible Research Pairings

In research settings, AOD-9604 (5 mg Vial) is sometimes paired with peptides such as:

• CJC-1295 (no DAC): For synergistic metabolic and GH-axis support
• Ipamorelin: For complementary body composition optimization
• BPC-157: For tissue recovery support during recomposition phases

When stacking with GH secretagogues, timing and fasting protocols should be coordinated for optimal results.

Supporting Factors for AOD-9604 Research

Factors recorded alongside this protocol include:

• Maintain caloric deficit or balanced nutrition aligned with body composition goals
• Regular cardiovascular and resistance training
• Adequate sleep (7–9 hours) for metabolic recovery
• Consistent fasting windows for morning administration

These factors can affect how research observations are interpreted.

AOD-9604 5mg Tolerability Notes

AOD-9604 has demonstrated excellent safety profiles in clinical trials involving over 900 participants. It does not affect insulin sensitivity, blood glucose levels, or IGF-1 production.

Some individuals report:

• Mild injection site reactions (redness, swelling)
• Occasional headache
• Gastrointestinal discomfort at higher doses

AOD-9604 5mg Storage Requirements

Unreconstituted

Store in a cool, dry environment at room temperature or refrigerated

Reconstituted

Refrigerate at 2–8°C (35.6–46.4°F)

Post-Mix Stability

Up to 4–6 weeks when properly refrigerated

• Protect from light at all times.
• Do not freeze reconstituted solution.
• Discard if solution becomes cloudy or discolored.
• Use sterile technique when accessing the vial.

This peptide is generally not recommended for:

• Pregnant or breastfeeding individuals
• Those with active cancer or history of malignancy
• Individuals with pituitary disorders
• Anyone advised otherwise by a healthcare professional

AOD-9604 5mg Purchasing and Research Supply Notes

Before ordering AOD-9604 (5 mg Vial), review the product label, available testing documents, and storage instructions.

Check the ResearchLabs listing for:

• Available testing documents
• Product strength and concentration
• Storage and handling instructions
• Current product availability

Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.